Clinical Trials Sponsored by Istituto per lo Studio e la Prevenzione Oncologica

Total 94 results

University of Florence
Azienda Ospedaliero-Universitaria Careggi; Istituto per lo Studio, la Prevenzione...

Recruiting

SLPI for Prostate Cancer

Prostate Cancer | Prostatic Neoplasm

Italy
Istituto Scientifico Romagnolo per lo Studio e...
Istituto Oncologico Romagnolo (IOR)

Recruiting

Prehabilitation in Geriatric Patients With Colorectal Neoplasia (PIGEON)

Colo-rectal Cancer

Italy
IRCCS San Raffaele Roma
Istituto per lo Studio, la Prevenzione e la Rete Oncologica; Department of...

Active, not recruiting

Serum Prevalence of SARS-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE) (SPARE)

Healthy | Chronic Disease

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

"Receptor Radionuclide Therapy With 177Lu-DOTATOC (LUFOR)

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer (OVERPASS)

Pancreatic Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

Cancer | Solid Tumor | Hematologic Malignancy | Oral Drug Administration

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients With Prostate Cancer. (F-PSMA)

Prostate Cancer | 18F-PSMA

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. (BIOPSTAGE)

Prostate Cancer | Diagnosis | 68Ga-PSMA PET/CT Guided Prostate Biopsy | Mp-3TMRI Guided Prostate Biopsy | TNM Staging

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. (HBO-RT)

High Grade Glioma | Malignant Glioma | Recurrent Glioma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma (MesoRT)

Malignant Pleural Mesothelioma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors (LUNET)

Neuroendocrine Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) (COLORE)

Rectal Carcinoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study (ABSIDE)

Malignant Melanoma of Skin Stage III | Malignant Melanoma of Skin Stage IV

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2 (IL2HD)

Metastatic Renal Cell Cancer | Malignant Melanoma, Metastatic

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas (SENECA)

Neuroendocrine Carcinoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. (ACDC)

Malignant Melanoma | Adjuvant Drug Therapy | Vaccin Therapy

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors (LUTHREE)

Neuroendocrine Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas (itTRIOlym)

Recurrent Disease | DLBCL | MCL

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Colorectal Cancer Metastatic

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Women With Primary Breast Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors (FAPI)

Solid Tumor, Unspecified, Adult

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST) (LUST)

Prostate Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation (PBReI)

Breast Cancer | Recurrent

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Medication Reconciliation in Oncologic Patients (PROF2)

Medication Reconciliation

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

A Phase II Study on Adjuvant Vaccination With Dendritic Cells Loaded With Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. (RaC-Ad)

Soft Tissue Sarcoma | Neuroendocrine Tumors | Vaccination | Head Neck Tumors | Rare Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (MESOVAX)

Progressive Disease | Mesothelioma, Malignant | Advanced Cancer | PD-L1 Negative

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC) (LU-PSMA)

Metastatic Castration Resistant Prostate Cancer | 68Ga-PSMA PET/CT Positive

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated (GaPSMA)

Prostate Cancer | 68Ga-PSMA HBED-PET/CT

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA) (WB-LuPSMA)

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy (THRIP)

Prostate Adenocarcinoma | Radiotherapy; Complications | Tomotherapy

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metastases of Solid Tumors (HIFU-Bone)

Solid Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy (YogaRT)

Quality of Life | Fatigue | Radiotherapy; Complications | Physiological Stress | Female Breast Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate (INO-CD22)

Acute Lymphoblastic Leukemia

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen

Gastrointestinal Cancer | CALCIUM LEVOFOLINATO (Ca-lev) | SODIUM LEVOFOLINATO (Na-lev)
Istituto Scientifico Romagnolo per lo Studio e...

Completed

A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer (met-HEReMYTA)

HER-2 Positive Breast Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation (TeRes)

Small Cell Lung Cancer Recurrent

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Withdrawn

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC (RENALVax-2)

Carcinoma, Renal Cell | Secondary | Vaccination

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Sequential Treatment Strategy for Metastatic Colorectal Cancer (ITACa)

Metastatic Colorectal Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC (VIVOS)

Non-small Cell Lung Cancer Metastatic

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) (ARTT)

Estrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative Neoplasm

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer (CAELYX)

HER-2 Positive Breast Cancer | Malignant Neoplasm of Breast

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients (MYME)

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

National Database of Bone Metastases (BDMO)

Bone Metastases

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours: (LUBASKET)

Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL) (PALTEL)

Cancer | Palliative Care

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Skin Toxicity by Oncological Therapies (SKINTOX)

Skin Toxicity

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? (MISS)

Breast Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma (Combi G-Vax)

Glioblastoma | Vaccination

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) (MMCI)

Diffuse Large B Cell Lymphoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors (BASKET PSMA)

Prostate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid Tumors

Italy

Clinical Trials Sponsored by Istituto per lo Studio e la Prevenzione Oncologica

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations